CorVel Co. (NASDAQ:CRVL) Director Jeffrey J. Michael sold 6,000 shares of the stock in a transaction on Thursday, August 9th. The shares were sold at an average price of $55.72, for a total value of $334,320.00. Following the sale, the director now owns 206,985 shares in the company, valued at approximately $11,533,204.20. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

NASDAQ:CRVL traded up $0.75 during midday trading on Monday, hitting $57.10. 22,800 shares of the company traded hands, compared to its average volume of 32,319. CorVel Co. has a 12-month low of $46.45 and a 12-month high of $61.20. The firm has a market capitalization of $1.06 billion, a PE ratio of 27.76 and a beta of 0.66.

CorVel (NASDAQ:CRVL) last released its earnings results on Tuesday, July 31st. The business services provider reported $0.62 earnings per share for the quarter. CorVel had a return on equity of 23.42% and a net margin of 6.78%. The business had revenue of $150.40 million for the quarter.

Hedge funds have recently added to or reduced their stakes in the business. Piedmont Investment Advisors LLC purchased a new stake in CorVel in the second quarter worth $121,000. SG Americas Securities LLC increased its stake in CorVel by 66.0% in the second quarter. SG Americas Securities LLC now owns 3,446 shares of the business services provider’s stock worth $186,000 after purchasing an additional 1,370 shares during the period. MetLife Investment Advisors LLC purchased a new stake in CorVel in the fourth quarter worth $282,000. Barclays PLC increased its stake in CorVel by 60.8% in the first quarter. Barclays PLC now owns 6,231 shares of the business services provider’s stock worth $315,000 after purchasing an additional 2,355 shares during the period. Finally, Eqis Capital Management Inc. purchased a new stake in CorVel in the second quarter worth $437,000. Institutional investors and hedge funds own 43.87% of the company’s stock.

Separately, BidaskClub upgraded CorVel from a “hold” rating to a “buy” rating in a report on Friday, June 22nd.

CorVel Company Profile

CorVel Corporation provides medical cost containment and managed care services to address the medical costs of workers' compensation benefits, automobile insurance claims, and group health insurance benefits. The company offers network solutions, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review.

Recommended Story: New Google Finance Tool and Screening Stocks

Insider Buying and Selling by Quarter for CorVel (NASDAQ:CRVL)

Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.